People with cardiovascular disease still have a high burden of risk factors for severe COVID
October 17, 2022
Smoking, Diabetes and Obesity - Not Preexisting Heart Disease - Bigger Risk of COVID-19 Death, Study Finds
October 17, 2022 —  A national study suggests that risk factors for cardiovascular disease, such as age, smoking and…
Read More
Low-cost blood pressure lowering drugs, statins and aspirin widely in the form of a single pill, also known as the polypill. McMaster University
October 17, 2022
The Polypill Could Avoid Millions of Premature Deaths, Heart Attacks and Strokes Every Year, Say Leading Cardiology Experts
October 17, 2022 —  Global Health has paid a deadly price for not using simple, low-cost blood pressure lowering drugs…
Read More
Allegheny Health Network’s Cardiovascular Institute announced today the expansion of its nationally recognized thoracic surgery program to AHN Wexford Hospital, marking the full-service hospital’s most recent milestone in providing access to the highest level of care to patients living in communities north of Pittsburgh. The program launched under the clinical direction of AHN cardiothoracic surgeon, Hiran C. Fernando, MD.
October 17, 2022
AHN Cardiovascular Institute Expands Thoracic Surgery Program to AHN Wexford Hospital
October 17, 2022 —  Allegheny Health Network’s (AHN) Cardiovascular Institute announced the expansion of its nationally…
Read More
Study data show clinically meaningful impact on quality of life and disease severity, even in the most complex patients
October 14, 2022
ABRE Clinical Study 36-Month Data Shows Sustained Effectiveness of Abre Venous Self-Expanding Stent System
October 14, 2022 —  Medtronic, a global leader in medical technology, announced the 36-month final results from the …
Read More
The HELIOSTAR Balloon Ablation Catheter's unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution
October 14, 2022
Biosense Webster Launches HELIOSTAR in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations
October 14, 2022 —  Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch…
Read More
Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP testinG, of Heart Failure therapies) study, announced the premature termination of the trial.
October 14, 2022
STRONG-HF Study in Patients Admitted for Acute Heart Failure (HF) Terminated Early for Superior Efficacy
October 14, 2022 —  Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid…
Read More
The data, collected during the transition from intravenous (IV) to oral levosimendan in the open-label extension (OLE) of the HELP (Hemodynamic Evaluation of Levosimendan in PH-HFpEF) trial, were presented at the Heart Failure Society of America (HFSA) Scientific Sessions 2022
October 13, 2022
Positive Data Presented at HFSA Annual Meeting Demonstrate Effects of Oral Levosimendan in Patients with Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
October 13, 2022 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing, and…
Read More
the U.S. Patent and Trademark Office has issued to the University of Iowa Research Foundation ("UIRF") U.S. Patent No. 11,414,704 titled COMPOSITIONS AND METHODS FOR DETECTING PREDISPOSITION TO CARDIOVASCULAR DISEASE, which is exclusively licensed to the Company from UIRF
October 13, 2022
Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
October 13, 2022 —  Cardio Diagnostics, Inc. , a pioneering precision cardiovascular testing company, announced that…
Read More
Zach Williams wanted to be a cancer researcher, but quick success in another area refocused his research on cardiovascular science. He was awarded a National Institutes of Health grant to fund his research for two years. Image courtesy of Clayton Metz/Virginia Tech.
October 13, 2022
Virginia Tech Graduate Student Earns NIH Support to Explore Promising Heart Finding
October 13, 2022 —  Zach Williams thought he’d become a cancer researcher when he joined Virginia Tech’s Translational…
Read More
The Delphi study results show Philips’ integrated echocardiography solution provides the tools required for baseline risk stratification and monitoring of cardio-oncology patients as recommended by the latest European Society of Cardiology (ESC) guidelines
October 12, 2022
Panel of Experts Highlights Clinical and Operational Benefits of Philips’ Integrated Echocardiography Solution
October 12, 2022 —   Following the recent European Society of Cardiology (ESC) Congress in Barcelona, Spain last month…
Read More
Study investigates metformin and other candidate drugs through a network medicine approach
October 12, 2022
Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative Research
October 12, 2022 —  Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible…
Read More
Renowned Stanford Cardiologist Brings Deep Clinical, Research, and Industry Expertise to Executive Team
October 12, 2022
HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer
October 12, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG…
Read More
Results now available for the first 10 patients being treated with the ELANA open heart bypass solution as part of a SAFE-CAB trial.
October 11, 2022
ELANA Heart Bypass Solution Shows Promising Preliminary Results in First-in-Human Trials
October 11, 2022 — The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass…
Read More
Researchers from the University of Minnesota Medical School found that patients with certain features on magnetic resonance imaging (MRI) of the heart are at much higher risk for cardiac sarcoidosis-related adverse outcomes.
October 11, 2022
Identifying Patients with Sarcoidosis at Risk for Bad Cardiac Outcomes
October 11, 2022 — Researchers from the University of Minnesota Medical School found that patients with certain…
Read More
Grant Proceeds Will Support Pre-Clinical Studies
October 11, 2022
Efemoral Medical Awarded Phase II SBIR Grant from NIH to Advance Treatment for Peripheral Artery Disease
October 11, 2022 —  Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it…
Read More
Kyle Walsh, MD
October 07, 2022
Identifying How Inflammation Affects Stroke Recovery
October 7, 2022 — A new research grant will enable University of Cincinnati researchers to learn more about how…
Read More
Ultromics, a digital health technology company pioneering the development of transformative heart failure diagnostics, has joined as a full partner The Accelerating Medicines Partnership® Heart Failure (AMP HF) including the National Institutes of Health (NIH) and the National Heart Lung and Blood Institute (NHLBI), managed by the Foundation for the National Institutes of Health (FNIH).
October 07, 2022
Ultromics joins FNIH Partnership to Transform Heart Failure Detection
October 7, 2022 —  Ultromics, a digital health technology company pioneering the development of transformative heart…
Read More
This is the first study to investigate the safety and tolerability of NR in a randomized, placebo-controlled trial of patients with heart failure, marking a milestone for future clinical research
October 07, 2022
ChromaDex Shares Promising Findings from Clinical Study Showcasing ​​the Safety and Tolerability of Nicotinamide Riboside (NR) in Heart Failure With Reduced Ejection Fraction
October 7, 2022 — ChromaDex Corp. announced promising findings from a clinical study, as reported in the peer-reviewed…
Read More
Rutgers study finds post-surgical hospitalization rates from left ventricular assist devices varied by socioeconomic factors
October 06, 2022
Lower-Income Patients with Heart Pumps More Likely Hospitalized with Major Bleeding, Infection or Heart Failure
October 6, 2022 —  The complications experienced by heart failure patients implanted with a left ventricular assist…
Read More
Research collaboration involving NYU Tandon School of Engineering, NYU Langone and the Food and Drug Administration will focus on biomarker data to improve performance analysis of stroke rehabilitation equipment. Image credit: Shidlovski
October 06, 2022
NYU Researchers Partner with FDA to Identify Biomarkers for Stroke Rehabilitation
October 6, 2022 —  Stroke is the leading cause of age-related motor disabilities and is becoming more prevalent in…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now